Historical Stock Price
ETFs Holding TARO »    TARO Split History »
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
09/19/2022 $31.29 $31.50 $30.39 $30.72 11.70K
09/20/2022 $30.25 $31.03 $30.01 $30.37 10.30K
09/21/2022 $30.72 $30.76 $28.88 $29.44 29.60K
09/22/2022 $29.50 $32.43 $28.56 $31.36 21.60K
09/23/2022 $30.71 $31.72 $29.94 $30.93 12.30K
Taro Pharmaceutical Industries is a multinational, science-based pharmaceutical company. Co. develops, manufactures and markets prescription and over-the-counter pharmaceutical products mainly in the U.S., Canada and Israel. Co.'s main focus includes semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules and tablets, in the dermatological and topical, cardiovascular, neuropsychiatric and anti-inflammatory therapeutic categories. Co. manufactures finished dosage form pharmaceutical products for sale in Israel and for export; and produces active pharmaceutical ingredients used in the manufacture of finished dosage form pharmaceutical products.
TARO historical stock prices picture
Taro Pharmaceutical Industries (TARO) has the following price history information. Looking back at TARO historical stock prices for the last five trading days, on September 19, 2022, TARO opened at $31.29, traded as high as $31.50 and as low as $30.39, and closed at $30.72. Trading volume was a total of 11.70K shares. On September 20, 2022, TARO opened at $30.25, traded as high as $31.03 and as low as $30.01, and closed at $30.37. Trading volume was a total of 10.30K shares. On September 21, 2022, TARO opened at $30.72, traded as high as $30.76 and as low as $28.88, and closed at $29.44. Trading volume was a total of 29.60K shares. On September 22, 2022, TARO opened at $29.50, traded as high as $32.43 and as low as $28.56, and closed at $31.36. Trading volume was a total of 21.60K shares. On September 23, 2022, TARO opened at $30.71, traded as high as $31.72 and as low as $29.94, and closed at $30.93. Trading volume was a total of 12.30K shares.

TARO Historical Stock Prices By Date:

TARO historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Taro Pharmaceutical Industries shares, starting with a $10,000 purchase of TARO, and working forward through the historical stock price information to today.

Growth of $10,000.00
With Dividends Reinvested

Start date: 09/27/2012
End date: 09/23/2022
Start price/share: $45.34
End price/share: $30.93
Starting shares: 220.56
Ending shares: 252.14
Dividends reinvested/share: $12.81
Total return: -22.01%
Average Annual Total Return: -2.46%
Starting investment: $10,000.00
Ending investment: $7,796.27
Years: 9.99
 
Growth of $10,000.00
Without Dividends Reinvested

Start date: 09/27/2012
End date: 09/23/2022
Start price/share: $45.34
End price/share: $30.93
Dividends collected/share: $12.81
Total return: -3.53%
Average Annual Total Return: -0.36%
Starting investment: $10,000.00
Ending investment: $9,645.97
Years: 9.99
Date Close
09/19/2022$30.72
09/20/2022$30.37
09/21/2022$29.44
09/22/2022$31.36
09/23/2022$30.93
TARO is categorized under the Healthcare sector; below are some other companies in the same sector:

TBIO Historical Stock Prices
TBRA Historical Stock Prices
TCMD Historical Stock Prices
TCON Historical Stock Prices
TDOC Historical Stock Prices
TEAR Historical Stock Prices
TECH Historical Stock Prices
TELK Historical Stock Prices
TENX Historical Stock Prices
TEVA Historical Stock Prices

Also explore: TARO shares outstanding history

Email EnvelopeFree TARO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

TARO Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2022, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.